Otolaryngology · Tampa, FL
NPI
1962494815
Since 2005
Specialty
Otolaryngology
Code 207Y00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
Suncoast ENT Surgical Specialists, 4714 N Armenia Ave. Ste 200
Tampa, FL, 33603
Phone (813) 872-8794
Groups this clinician bills Medicare through
Medicare paid, 2024
$95K
1,209 services
Medicare patients, 2024
463
Average age 77
Drug cost, 2024
$97K
954 prescriptions
Company payments, 2025
$293
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sanford R Dolgin was code 99213 (office e&m - established), 231 times for 167 patients. In total Sanford R Dolgin billed 1,209 services in 74 codes, and Medicare paid $95K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-05-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 231 | 167 | $62.09 | $14K |
| 99212 Office E&M - Established | Office | 183 | 151 | $38.32 | $7,012 |
| 69210 Other Organ Systems | Office | 171 | 143 | $28.64 | $4,897 |
| 99203 Office E&M - New | Office | 127 | 127 | $75.04 | $9,530 |
| 31575 Other Organ Systems | Office | 110 | 99 | $93.06 | $10K |
| 99214 Office E&M - Established | Office | 63 | 55 | $91.67 | $5,775 |
| 31231 Nasal/Sinus Endoscopy | Office | 59 | 50 | $133.25 | $7,862 |
| 99202 Office E&M - New | Office | 50 | 50 | $45.18 | $2,259 |
| 99204 Office E&M - New | Office | 44 | 44 | $116.48 | $5,125 |
| G0268 Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 30 | 29 | $38.56 | $1,157 |
| 92511 Treatment - Miscellaneous | Office | 24 | 23 | $80.30 | $1,927 |
| 92504 E&M - Miscellaneous | Office | 17 | 13 | $20.40 | $347 |
By year: 2022 $104K for 1,338 services; 2023 $105K for 1,301 services; 2024 $95K for 1,209 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sanford R Dolgin prescribed most often to Medicare patients was Ipratropium Bromide, with 297 prescriptions and refills. In total Sanford R Dolgin wrote 954 Medicare prescriptions that cost $97K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ipratropium Bromide Generic | 297 | 391 | 105 | $12K |
| Valacyclovir Valacyclovir Hcl | 103 | 146 | 30 | $9,426 |
| Montelukast Sodium Generic | 63 | 105 | 15 | $368 |
| Azelastine Hcl Generic | 63 | 92 | 21 | $892 |
| Fluticasone Propionate Generic | 44 | 73 | 16 | $777 |
| Famciclovir Generic | 44 | 74 | 12 | $10K |
| Lidocaine Hcl Viscous Lidocaine Hcl | 36 | 36 | 16 | $357 |
| Tramadol Hcl Generic | 32 | 32 | 28 | $153 |
| Nystatin-Triamcinolone Nystatin/Triamcinolone Acet | 25 | 25 | 22 | $499 |
| Methylprednisolone Generic | 23 | 23 | 22 | $172 |
| Mometasone Furoate Generic | 21 | 24 | 14 | $496 |
| Ciprofloxacin Hcl Generic | 18 | 18 | 11 | $193 |
| Dupixent Pen Dupilumab | 16 | 16 | Under 11 | $55K |
| Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid | 15 | 25 | Under 11 | $28.54 |
| Ofloxacin Generic | 14 | 14 | 12 | $959 |
Brand drugs: 26 claims; generic drugs: 928 claims; opioid claims: 33.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sanford R Dolgin $293 ($293 in general payments such as food, travel and fees) from 8 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $55.87.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $55.87 |
| GlaxoSmithKline, LLC. GSK | 3 | $49.22 |
| Inspire Medical Systems, Inc. INSP | 1 | $47.13 |
| Merck Sharp & Dohme LLC MRK | 1 | $41.95 |
| Genzyme Corporation SNY | 1 | $38.75 |
| Amgen Inc. AMGN | 1 | $23.73 |
| Integra LifeSciences Corporation IART | 1 | $18.46 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $17.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.